Rasburicase for the treatment of tumor lysis in hematological malignancies.
about
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapyThe optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis.Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment RegimensTumor lysis syndrome in an extraskeletal osteosarcoma: a case report and review of the literature.SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice
P2860
Rasburicase for the treatment of tumor lysis in hematological malignancies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@en
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@nl
type
label
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@en
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@nl
prefLabel
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@en
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@nl
P2093
P2860
P356
P1476
Rasburicase for the treatment of tumor lysis in hematological malignancies.
@en
P2093
Giulia Malaguarnera
Maria Giordano
Mariano Malaguarnera
P2860
P356
10.1586/EHM.11.73
P577
2012-02-01T00:00:00Z